Загрузка...

Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction Period

Optimal integration of molecularly targeted therapies such as tyrosine kinase inhibitors (TKI) with concurrent chemotherapy and radiation (CRT) to improve outcomes in genotype-defined cancers remains a current challenge in clinical settings. Important questions regarding optimal scheduling and lengt...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Res
Главные авторы: McClatchy, David M., Willers, Henning, Hata, Aaron N., Piotrowska, Zofia, Sequist, Lecia V., Paganetti, Harald, Grassberger, Clemens
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7669719/
https://ncbi.nlm.nih.gov/pubmed/32907839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-3883
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!